Patent details

Basic Information

Publication number:

EP2270026

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100124973

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compounds for proteasome enzyme inhibition

French Title of Invention:

Composés pour inhibition d'enzyme de protéasome

German Title of Invention:

Verbindungen zur Proteasomenzyminhibition

SPC Number:

Dates

Filing date:

08/08/2005

Grant date:

18/05/2016

EP Publication Date:

18/05/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/01/2011

EP B1 Publication Date:

18/05/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/08/2016

Expiration date:

08/08/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/08/2005

 

 

Name:

Onyx Therapeutics Inc.

Address:

249 E. Grand Avenue, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

Smyth Mark S.

Address:

United States (US)

2

Name:

Laidig Guy J.

Address:

United States (US)

Priority

1

Priority Number:

599401 P

Priority Date:

06/08/2004

Priority Country:

United States (US)

2

Priority Number:

610001 P

Priority Date:

14/09/2004

Priority Country:

United States (US)

3

Priority Number:

106879

Priority Date:

14/04/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 5/103;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages